HOME >> MEDICINE >> NEWS
Concern over rising rates of syphilis in England

Syphilis is on the increase again. In this week's BMJ, Lorraine Doherty and colleagues report on four recent outbreaks in England and discuss the public health measures needed to contain it.

Between 1998 and 2000, the number of cases of infectious syphilis in England more than doubled - from 172 to 372 in men and 102 to 156 in women. Rates were highest in London and in north west England.

These increases are largely due to several localised outbreaks, and indicate that unsafe sexual behaviour continues among both the heterosexual and homosexual populations in England, say the authors.

Few general practitioners will have dealt with a case of infectious syphilis, but these outbreaks emphasise the importance of sustained multidisciplinary public health action in this area, they add.

The general public, certain groups at risk, and relevant health professionals should be aware of the risks of acquiring syphilis and the symptoms and signs of acute infection, they conclude.


'"/>

Contact: Emma Wilkinson
ewilkinson@bmj.com
44-207-383-6529
BMJ-British Medical Journal
18-Jul-2002


Page: 1

Related medicine news :

1. Concerns over the future of childrens health care in British general practice
2. Concerns about fertility affect treatment decisions in one-third of young breast cancer patients
3. Concern about pain reliever side effects, many patients take more than recommended
4. Concern for European public health as EU border extends to the east
5. Concern over poor facilities for young people with mental illness
6. Concerns over the value of animal experiments
7. Concern over rise in pedestrian and cyclist injuries
8. Concerns over national policy on infertility treatment
9. Concern over billion dollar alternative medicine bill
10. Concern about future health problems goes up in smoke
11. Lack Of Data For New Heart Drugs Is Causing Concern

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Concern over rising rates syphilis England

(Date:6/19/2013)... along with the Japanese government and the Bill ... bolster Japan,s contribution to global health through the ... a press conference held as a side event ... Development (TICAD V). , Representatives from each of ... Labour and Welfare, the Ministry of Foreign Affairs, ...
(Date:6/19/2013)... Dental professionals are increasingly monitoring end tidal carbon ... sedation, a patient’s breathing depth and rate decrease. ... to update its guidelines to require etCO2 monitoring, or ... to increase safety in procedures. This amendment to Section ... effect July 1. , The Oregon Board of ...
(Date:6/19/2013)... Ariz. (PRWEB) June 19, 2013 PREFERRED ... WellCare of Arizona to offer a new ... Maricopa, Pima, La Paz, Yavapai and Mohave, Arizona counties. ... Mohave counties were effective January 1, 2013 and Maricopa ... 2014. , WellCare, Inc., the parent company of WellCare ...
(Date:6/19/2013)... Brightree LLC , the leading provider of cloud-based ... care industry, has been ranked for the first time - ... (HCI 100) list. This prestigious list features the top ... revenue during the last fiscal year. Since 2005, Brightree’s revenue ... the company has built its organization to more than 500 ...
(Date:6/19/2013)... Guests at the Residence Inn Scottsdale Paradise Valley ... go to bed or rise early thanks to a new ... , Crafty travelers will have a little extra change in ... Paradise Valley hotel’s Book Early and Save Up to ... notice, guests can enjoy the year-round Scottsdale sunshine in deluxe ...
Breaking Medicine News(10 mins):Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 2Health News:GHIT Fund celebrates historic beginning of Japanese R&D initiative in global health 3Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 2Health News:Required Capnography Monitoring Growing Trend Among National and State Healthcare Organizations 3Health News:PREFERRED Therapy Providers, Inc. and WellCare of Arizona Finalize Their Agreement to Offer Medicare Advantage Plan to PREFERRED's Arizona Provider Network 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 2Health News:Brightree Debuts on List of Top 100 Healthcare Technology Companies 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 2Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 3Health News:Plan Ahead and Save Big With New Deal From Residence Inn Scottsdale Paradise Valley 4
(Date:6/19/2013)... ZIONA, Israel , June 19, ... that results from a phase I study in volunteers, ... advanced Parkinson,s patients, of ND0612, were presented at the ... ND0612 is a proprietary levodopa/carbidopa liquid drug formula under ... patch that would maintain constant levodopa plasma concentrations. ...
(Date:6/19/2013)... , June 19, 2013   Life ... announces a licensing agreement granting Suzhou Ribo Life ... manufacture siRNA therapeutics in China ... will formulate proprietary siRNA molecules in combination with ... to address human diseases with high unmet medical ...
(Date:6/19/2013)... INDIANAPOLIS , 19. Juni 2013 ... bekannt, dass mit der Entwicklung von ... bahnbrechender Schritt in der Beschichtung mit ... die Vorteile von biokompatiblem Parylene mit ... effektive Beseitigung schädlicher Mikroorganismen auf beschichteten ...
Breaking Medicine Technology:NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 2NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 3NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 4NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 5NeuroDerm Announces Presentation of Data from Studies Evaluating ND0612, an Investigational Levodopa Continuous Administration Drug, in Healthy Volunteers and in Patients with Advanced Parkinson's Disease 6Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 2Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 3Life Technologies Signs Licensing Agreement with Suzhou Ribo Life Sciences for Development of siRNA Therapeutics in China 4Specialty Coating Systems gibt die Einführung einer neuen antimikrobiellen Parylene-Technologie bekannt 2
Cached News: